Ingredients: Analysis of active ingredients, intermediates, and excipients in pharmaceutical development and manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ingredients
Trends, market analysis, and market growth reports on pharmaceutical ingredient suppliers and manufacturers. Sourcing and supply of active pharmaceutical ingredients (APIs), intermediates, excipients.

Fluorination Remains Key Challenge in API Synthesis

October 2, 2014

Pharmaceutical Technology

Safer fluorinating reagents and access to GMP fluorination capabilities remain challenges in API synthesis.

Asymmetric Synthesis Continues to Advance

September 2, 2014

Pharmaceutical Technology

A survey of the recent literature reveals numerous advances in asymmetric chemocatalysis.

QbD in API Manufacturing

September 2, 2014

Pharmaceutical Technology

With a quality-by-design approach, robust processes consistently can help deliver quality product.

Exploring a New Approval Process for Continued Excipient Innovation

September 1, 2014

Pharmaceutical Technology

New excipients and improvements to existing excipients are needed to facilitate access to new drugs for patients.

API Developers Pass Inspections and Upgrade Capabilities

September 1, 2014

Pharmaceutical Technology

API development and manufacturing companies expanded their capabilities, built partnerships, and achieved milestones in regulatory inspections.

Meeting the Challenges of Excipient Variability

September 1, 2014

Pharmaceutical Technology

The quality and composition of excipients can vary due to environmental factors, processing methods, raw material quality, manufacturing location changes, and even operator actions.

Taking Action on Elemental Impurities

September 1, 2014

Pharmaceutical Technology

Changing regulations are impacting the identification and monitoring of variable materials in excipients.

Fast Locator 2014-2015 Index

August 18, 2014

View companies' outsourcing profiles from PharmTech's 2014 Outsourcing Resources Fast Locator Index in the following categories.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

August 2, 2014

Pharmaceutical Technology

Customers are looking to reduce risk, increase performance, and optimize productivity.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here